{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:31:52Z","timestamp":1778707912144,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Disease caused by Cryptococcus gattii typically manifests as meningoencephalitis or pulmonary nodules. Endobronchial lesions are rare, and most cases are caused by Cryptococcus neoformans. We describe here a case of endobronchial disease in a child caused by C gattii. The disease spectrum in this patient was notable for the discovery of anti\u2013granulocyte macrophage colony-stimulating factor autoantibodies.<\/jats:p>","DOI":"10.1093\/jpids\/piy100","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T19:45:04Z","timestamp":1537386304000},"page":"67-70","source":"Crossref","is-referenced-by-count":12,"title":["Unusual Presentation of Severe Endobronchial Obstruction Caused by Cryptococcus gattii in a Child"],"prefix":"10.1093","volume":"9","author":[{"given":"Julie","family":"Huynh","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Microbiology, Children\u2019s Hospital Westmead, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Saddi","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Children\u2019s Hospital Westmead, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Cooper","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Children\u2019s Hospital Westmead, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan T","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Paediatric Otolaryngology, Children\u2019s Hospital Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, University of Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiland","family":"Meyer","sequence":"first","affiliation":[{"name":"Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Westmead Clinical School\u2013Sydney Medical School, Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Westmead Hospital, Westmead Institute for Medical Research, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Chen","sequence":"first","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, ICPMR, New South Wales Health Pathology, University of Sydney, Westmead Hospital, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Isaacs","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Microbiology, Children\u2019s Hospital Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, University of Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"key":"2020022803494658100_CIT0001","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1128\/JCM.01072-09","article-title":"Identification of Cryptococcus gattii by use ofl-canavanine glycine bromothymol blue medium and DNA sequencing","volume":"47","author":"Klein","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2020022803494658100_CIT0002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","article-title":"Molecular typing of IberoAmerican Cryptococcus neoformans isolates","volume":"9","author":"Meyer","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2020022803494658100_CIT0003","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.pathol.2017.12.315","article-title":"The expanding clinical utility of anti GM-CSF antibody testing in assessment of patients with cryptococcal infection","volume":"50","author":"Knezevic","year":"2018","journal-title":"Pathology"},{"key":"2020022803494658100_CIT0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3201\/eid1301.060827","article-title":"Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA","volume":"13","author":"MacDougall","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2020022803494658100_CIT0005","doi-asserted-by":"crossref","DOI":"10.3201\/eid1607.100106","article-title":"Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007","volume":"16","author":"Okamoto","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"2020022803494658100_CIT0006","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","article-title":"Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen","volume":"53","author":"Harris","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020022803494658100_CIT0007","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020022803494658100_CIT0008","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/02681219680000311","article-title":"Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects","volume":"34","author":"Speed","year":"1996","journal-title":"J Med Vet Mycol"},{"key":"2020022803494658100_CIT0009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoformans","volume":"21","author":"Speed","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2020022803494658100_CIT0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/LBR.0b013e3181cd95da","article-title":"Endobronchial cryptococcosis: a rare cause of lung collapse","volume":"17","author":"Artinian","year":"2010","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2020022803494658100_CIT0011","first-page":"e32","article-title":"Endobronchial pulmonary cryptococcosis and tuberculosis in an immunocompetent host","volume":"53","author":"Thomas","year":"2012","journal-title":"Singapore Med J"},{"key":"2020022803494658100_CIT0012","first-page":"E170","article-title":"A case report of pulmonary cryptococcosis presenting as endobronchial obstruction","volume":"5","author":"Zhou","year":"2013","journal-title":"J Thorac Dis"},{"key":"2020022803494658100_CIT0013","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2169\/internalmedicine.53.1616","article-title":"Pulmonary cryptococcosis with endobronchial lesions and meningitis","volume":"53","author":"Odashima","year":"2014","journal-title":"Intern Med"},{"key":"2020022803494658100_CIT0014","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/rcr2.64","article-title":"Endobronchial cryptococcosis induced by Cryptococcus gattii mimicking metastatic lung cancer","volume":"2","author":"Nakashima","year":"2014","journal-title":"Respirol Case Rep"},{"key":"2020022803494658100_CIT0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1751-0813.1997.tb14377.x","article-title":"Nasopharyngeal cryptococcosis","volume":"75","author":"Malik","year":"1997","journal-title":"Aust Vet J"},{"key":"2020022803494658100_CIT0016","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2020022803494658100_CIT0017","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2169\/internalmedicine.46.6249","article-title":"Pulmonary cryptococcosis presenting as endobronchial lesions in a patient under corticosteroid treatment","volume":"46","author":"Inoue","year":"2007","journal-title":"Intern Med"},{"key":"2020022803494658100_CIT0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1726-4901(09)70129-7","article-title":"Primary pulmonary cryptococcosis presenting as endobronchial tumor with left upper lobe collapse","volume":"68","author":"Chang","year":"2005","journal-title":"J Chin Med Assoc"},{"key":"2020022803494658100_CIT0019","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10156-008-0617-0","article-title":"An asymptomatic case of pulmonary cryptococcosis with endobronchial polypoid lesions and bilateral infiltrative shadow","volume":"14","author":"Shimizu","year":"2008","journal-title":"J Infect Chemother"},{"key":"2020022803494658100_CIT0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4103\/0970-2113.120618","article-title":"Pulmonary cryptococcosis: an unusual presentation","volume":"30","author":"Babu","year":"2013","journal-title":"Lung India"},{"key":"2020022803494658100_CIT0021","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020022803494658100_CIT0022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1074-7613(01)00218-7","article-title":"GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1","volume":"15","author":"Shibata","year":"2001","journal-title":"Immunity"},{"key":"2020022803494658100_CIT0023","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa062505","article-title":"GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis","volume":"356","author":"Uchida","year":"2007","journal-title":"N Engl J Med"},{"key":"2020022803494658100_CIT0024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00002030-199901140-00007","article-title":"Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients","volume":"13","author":"Tascini","year":"1999","journal-title":"AIDS"},{"key":"2020022803494658100_CIT0025","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J Immunol"},{"key":"2020022803494658100_CIT0026","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"2020022803494658100_CIT0027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.130.1.227","article-title":"An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis","volume":"130","author":"Venkateshiah","year":"2006","journal-title":"Chest"},{"key":"2020022803494658100_CIT0028","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1183\/09031936.00160908","article-title":"Rituximab therapy in autoimmune pulmonary alveolar proteinosis","volume":"33","author":"Borie","year":"2009","journal-title":"Eur Respir J"},{"key":"2020022803494658100_CIT0029","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1183\/09031936.00197710","article-title":"An open-label trial of rituximab therapy in pulmonary alveolar proteinosis","volume":"38","author":"Kavuru","year":"2011","journal-title":"Eur Respir J"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/9\/1\/67\/32696869\/piy100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/9\/1\/67\/32696869\/piy100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T23:41:04Z","timestamp":1662075664000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/9\/1\/67\/5136517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,19]]},"published-print":{"date-parts":[[2020,2,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piy100","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2018,10,19]]}}}